Cargando…
Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer
BACKGROUND: Apolipoprotein A-I (ApoA-I), which recently attracted great attention as an important protein related to the increasing risk of various cancers, is a factor closely related to metabolic diseases such as ardiovascular diseases and atherosclerosis. However, the diagnostic and prognostic va...
Autores principales: | Shi, Hui, Huang, Haidong, Pu, Jin, Shi, Dongchen, Ning, Yunye, Dong, Yuchao, Han, Yiping, Zarogoulidis, Paul, Bai, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199218/ https://www.ncbi.nlm.nih.gov/pubmed/30410356 http://dx.doi.org/10.2147/OTT.S170227 |
Ejemplares similares
-
Multiple guided technologies based on radial probe endobronchial
ultrasound for the diagnosis of solitary peripheral pulmonary lesions: a
single-center study
por: Haidong, Huang, et al.
Publicado: (2017) -
The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
por: Shi, Cong, et al.
Publicado: (2022) -
Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors
por: Kurian, Jujju Jacob, et al.
Publicado: (2018) -
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
por: Shi, Cong, et al.
Publicado: (2022) -
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)